Variant report
Variant | esv3518953 |
---|---|
Chromosome Location | chr13:76608702-76612872 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559570714 | chr13:76608722-76608723 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs7990448 | chr13:76608729-76608730 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs541984095 | chr13:76608745-76608746 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs1841664 | chr13:76608774-76608775 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs186966594 | chr13:76608783-76608784 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs191390870 | chr13:76608790-76608791 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs528047352 | chr13:76608811-76608812 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs528093246 | chr13:76608862-76608863 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546921634 | chr13:76608864-76608865 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs181314734 | chr13:76608886-76608887 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs535665752 | chr13:76608932-76608933 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185968654 | chr13:76608936-76608937 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568940582 | chr13:76608958-76608959 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs7990535 | chr13:76608964-76608965 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs558778300 | chr13:76608965-76608966 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs113515321 | chr13:76608993-76608994 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs148735365 | chr13:76609020-76609021 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs550739982 | chr13:76609033-76609034 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs34423645 | chr13:76609034-76609035 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs553266524 | chr13:76609053-76609054 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs7991027 | chr13:76609066-76609067 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs9573723 | chr13:76609073-76609074 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs563942954 | chr13:76609115-76609116 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs575741575 | chr13:76609144-76609145 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs182418652 | chr13:76609153-76609154 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs563981011 | chr13:76609177-76609178 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs10543750 | chr13:76609198-76609199 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs370166653 | chr13:76609202-76609203 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs528105598 | chr13:76609310-76609311 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs56198072 | chr13:76609313-76609314 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs561642741 | chr13:76609315-76609316 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs550286804 | chr13:76609399-76609400 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575466077 | chr13:76609402-76609403 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs77144726 | chr13:76609442-76609443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs529815758 | chr13:76609519-76609520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs375542564 | chr13:76609550-76609551 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs142285535 | chr13:76609625-76609626 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs546793712 | chr13:76609643-76609644 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs566602467 | chr13:76609715-76609716 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187805929 | chr13:76609716-76609717 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs146295615 | chr13:76609718-76609719 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs552961564 | chr13:76609788-76609789 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs115813158 | chr13:76609878-76609879 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs568098272 | chr13:76609920-76609921 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs577669649 | chr13:76609956-76609957 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs139777989 | chr13:76609976-76609977 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs191206753 | chr13:76609981-76609982 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs17065508 | chr13:76609997-76609998 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs146620554 | chr13:76609998-76609999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs79838484 | chr13:76610042-76610043 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:76605000-76609600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr13:76605400-76609600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr13:76608000-76612000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr13:76608600-76609000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr13:76609000-76610400 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
6 | chr13:76609600-76610200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
7 | chr13:76609600-76611000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
8 | chr13:76609600-76613800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr13:76609800-76610800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr13:76609800-76610800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
11 | chr13:76609800-76611000 | Enhancers | Muscle Satellite Cultured Cells | -- |
12 | chr13:76610400-76610600 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
13 | chr13:76610400-76611400 | Enhancers | K562 | blood |
14 | chr13:76610400-76611600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
15 | chr13:76610600-76611400 | Enhancers | Brain Anterior Caudate | brain |
16 | chr13:76610600-76611600 | Enhancers | Fetal Lung | lung |
17 | chr13:76610600-76611800 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
18 | chr13:76610600-76612400 | Enhancers | Fetal Thymus | thymus |
19 | chr13:76611200-76612000 | Enhancers | Thymus | Thymus |
20 | chr13:76611400-76613000 | Weak transcription | Brain Anterior Caudate | brain |
21 | chr13:76611600-76612200 | Weak transcription | Fetal Lung | lung |
22 | chr13:76611800-76613200 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |